IL33 and pancreatitis: In coxsackie B virus-induced pancreatitis, the administration of IL-33 enhances CD8+ T-cells and the IFN-γ-dependent antiviral immune response, resulting in a decrease in viral loads and the attenuation of pancreatitis [33].